| Code | 6250D | ||||||||||
| MA number | 21/0291/20-S | ||||||||||
| Product Form: | tbl flm 60x500 mg (blis.Al/PVC/PE/PVDC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/PVC/PE/PVDC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 23.12.2020 |
| Validity: | 23.12.2025 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Levetiracetam Stada Arzneimittel_12.2021.pdf
|
| PIL: |
PIL_Levetiracetam Stada Arzneimittel_04.2024.pdf
|
| Safety feature | Yes |
| Data update: | 19.03.2021 |
